Use of Bioclinical Markers for the Assessment and Treatment of Children with Pervasive Developmental Disorders
- 1 January 1989
- journal article
- research article
- Published by S. Karger AG in Neuropsychobiology
- Vol. 22 (3) , 117-124
- https://doi.org/10.1159/000118604
Abstract
The method presented is based on the 3-dimensional bioclinical examination of autistic children. The covariations of behavior ratings, electrophysiological (cortical evoked potentials) and biochemical (urinary monoamine metabolites) measurements are analyzed. The systematic application of these markers provides precise information for a more rational application of therapeutics. It could help to better understand the underlying mechanisms of autism.Keywords
This publication has 24 references indexed in Scilit:
- HVA and MHPG in urine of premature infantsPsychiatry Research, 1981
- Effects of pyridoxine and magnesium on autistic symptoms?Initial observationsJournal of Autism and Developmental Disorders, 1981
- Cerebrospinal fluid, plasma, and urinary MHPG in childrenLife Sciences, 1981
- An electrophysiologic indication of auditory processing defects in autismPsychiatry Research, 1980
- BEHAVIOR CHECKLIST FOR IDENTIFYING SEVERELY HANDICAPPED INDIVIDUALS WITH HIGH LEVELS OF AUTISTIC BEHAVIORJournal of Child Psychology and Psychiatry, 1980
- Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)Journal of Autism and Developmental Disorders, 1980
- Event-related potentials evoked by sensory stimulation in normal, mentally retarded and autistic childrenElectroencephalography and Clinical Neurophysiology, 1980
- Age-related changes in catecholamine metabolites of human urine from birth to adulthoodJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- A Neurological Model for Childhood AutismArchives of Neurology, 1978
- MODIFICATIONS IN URINARY HOMOVANILLIC-ACID AFTER INGESTION OF VITAMIN-B6 - FUNCTIONAL-STUDY IN AUTISTIC-CHILDREN1978